NCT06073145Completed
Transcranial Doppler Using Wearable Ultrasound Patch
Non-invasive Monitoring of Blood Flow in the Brain by Using a Wearable Ultrasound Patch
Source: ClinicalTrials.gov · Last updated 10 Apr 2024
Brief summary (registry, in English)
The main objective of this research is to measure the Doppler signal by the ultrasonic patch. Blood flow measurement is critical for vasospasm, stroke, and embolism monitoring on patients in the ICU or understanding the neurovascular coupling on different subjects. Currently, A conventional transcranial Doppler (TCD) probe is widely used for these applications. A headset design must be applied and fixed on the participants to obtain stable blood flow spectra. However, the TCD headset is operator dependent. The operator needs to be a trained expert and hold the ultrasound probe to get accurate blood flow velocity information. The stretchable and wearable non-invasive ultrasonic patch can not only free the operator's hands but can also provide long-term continuous monitoring, which is not possible by using the current operator-dependent ultrasound machine. The device can be conformal to the skin and attached to the skin surface.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 36 (actual)
- First submitted
- 13 Sept 2023
- Start date
- Sept 2022
- Primary completion date
- Apr 2024
- Lead sponsor
- University of California, San Diego
- Diseases
- Stroke
- NCT number
- NCT06073145
What you commit to
- Study type: Observational
- Participants enrolled: 36
- From Sept 2022 to the primary completion date, Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- History of the following conditions: Heart attack, low blood pressure, aortic stenosis/carotid artery stenosis (also known as heart valve disease), glaucoma (a group of eye conditions that damage the optic nerve) or retinopathy (a disease of the eye retina).
Other
- Inability to sign the informed consent.
Who the study is looking for
- Able to provide informed consent.
- In relatively good health with no serious medical conditions.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Structural and Materials Engineering (SME) building Room 310 Coordinator of this site? Confirm its status | San Diego | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.